Get startedLog in
    Picture of Inmune Bio logo

    INMB — Inmune Bio News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapMomentum Trap
    All News

    INmune Bio's Alzheimer's drug fails to meet main goal in mid-stage study

    Picture of Inmune Bio logoInmune Bio
    30/06/2025 12:33
    June 30 (Reuters) - INmune Bio INMB.O said on Monday its experimental Alzheimer's  drug failed to improve cognitive functions in patients with early stages of the mind-robbing disease in a mid-stage study, sending its shares plunging nearly 59% in premarket trading.

 (Reporting by Mariam Sunny in Bengaluru; Editing by Alan Barona and Sriraj Kalluvila)

 ((Mariam.ESunny@thomsonreuters.com))

    Recent news on Inmune Bio

    See all news